GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Panamera Holdings Corp (OTCPK:PHCI) » Definitions » Sloan Ratio %

Panamera Holdings (Panamera Holdings) Sloan Ratio % : 0.00% (As of Jan. 2024)


View and export this data going back to 2016. Start your Free Trial

What is Panamera Holdings Sloan Ratio %?

Richard Sloan from the University of Michigan was first to document what is referred to as the "accrual anomaly". His 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones.

Panamera Holdings's Sloan Ratio for the quarter that ended in Jan. 2024 was 0.00%.

As of Jan. 2024, Panamera Holdings has a Sloan Ratio of 0.00%, indicating the company is in the safe zone and there is no funny business with accruals.


Panamera Holdings Sloan Ratio % Historical Data

The historical data trend for Panamera Holdings's Sloan Ratio % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Panamera Holdings Sloan Ratio % Chart

Panamera Holdings Annual Data
Trend Jul15 Jul16 Jul17 Jul18 Jul19 Jul20 Jul21 Jul22 Jul23
Sloan Ratio %
Get a 7-Day Free Trial Premium Member Only - - - - -

Panamera Holdings Quarterly Data
Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
Sloan Ratio % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Panamera Holdings's Sloan Ratio %

For the Medical Care Facilities subindustry, Panamera Holdings's Sloan Ratio %, along with its competitors' market caps and Sloan Ratio % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Panamera Holdings's Sloan Ratio % Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Panamera Holdings's Sloan Ratio % distribution charts can be found below:

* The bar in red indicates where Panamera Holdings's Sloan Ratio % falls into.



Panamera Holdings Sloan Ratio % Calculation

Earnings contain a lot of non cash earnings which is called accruals. The Sloan ratio is a way to identify firms with low non-cash or accrual-derived earnings relative to their cash flow.

Panamera Holdings's Sloan Ratio for the fiscal year that ended in Jul. 2023 is calculated as

Sloan Ratio=(Net Income (A: Jul. 2023 )-Cash Flow from Operations (A: Jul. 2023 )
-Cash Flow from Investing (A: Jul. 2023 ))/Total Assets (A: Jul. 2023 )
=(-7.125--0.098
-0)/0.13
=-5,405.38%

Panamera Holdings's Sloan Ratio for the quarter that ended in Jan. 2024 is calculated as

Sloan Ratio=(Net Income (TTM)-Cash Flow from Operations (TTM))
-Cash Flow from Investing (TTM))/Total Assets (Q: Jan. 2024 )
=(-7.213--0.175
-0)/0.009
=-78,200.00%

Panamera Holdings's Net Income for the trailing twelve months (TTM) ended in Jan. 2024 was -0.009 (Apr. 2023 ) + -7.099 (Jul. 2023 ) + -0.063 (Oct. 2023 ) + -0.042 (Jan. 2024 ) = $-7.21 Mil.
Panamera Holdings's Cash Flow from Operations for the trailing twelve months (TTM) ended in Jan. 2024 was -0.004 (Apr. 2023 ) + -0.085 (Jul. 2023 ) + -0.062 (Oct. 2023 ) + -0.024 (Jan. 2024 ) = $-0.18 Mil.
Panamera Holdings's Cash Flow from Investing for the trailing twelve months (TTM) ended in Jan. 2024 was 0 (Apr. 2023 ) + 0 (Jul. 2023 ) + 0 (Oct. 2023 ) + 0 (Jan. 2024 ) = $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Panamera Holdings  (OTCPK:PHCI) Sloan Ratio % Explanation

A former University of Michigan researcher, Richard Sloan's 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones. In fact, for the 40-year period between 1962 and 2001, buying the lowest accrual companies and shorting the highest accrual companies resulted in an average annual compounded return of 18%, more than double the S&P 500's 7.4% annual return over the same period.

According to How to Beat the Market with the Sloan Ratio:

If the Sloan Ratio is between -10% and 10%, the company is in the safe zone and there is no funny business with accruals.

If the Sloan Ratio is less than between -25% and -10% on the negative side, and between 10% and 25% on the positive side, this is a warning stage of accrual build up.

If the Sloan Ratio is less than -25% or greater than 25%, and this ratio is consistent over several quarters or even years, be careful. Earnings are highly likely to be made up of accruals.

As of Jan. 2024, Panamera Holdings has a Sloan Ratio of 0.00%, indicating the company is in the safe zone and there is no funny business with accruals.


Panamera Holdings Sloan Ratio % Related Terms

Thank you for viewing the detailed overview of Panamera Holdings's Sloan Ratio % provided by GuruFocus.com. Please click on the following links to see related term pages.


Panamera Holdings (Panamera Holdings) Business Description

Traded in Other Exchanges
N/A
Address
5051 Westheimer, Suite 1200, Houston, TX, USA, 77056
Panamera Holdings Corp, formerly Panamera Healthcare Corp is a development stage company helping clients navigate the complexities of a healthcare system in transition.
Executives
T Benjamin Jennings director, 10 percent owner, officer: Chairman, CEO, President 2752 KINGS RETREAT CIRCLE, KINGWOOD TX 73025
Stanley F Wilson director, officer: Secretary, General Counsel 6711 EAST CAMELBACK ROAD 17, SCOTTSDALE AZ 85251
Christopher Barakat director 2752 KINGS RETREAT CIRCLE, KINGWOOD TX 77345
Ernest Joseph Diaz director, 10 percent owner 2410 W. MEMORIAL RD, SUTIE C406, OKLAHOMA CITY OK 73134
Curtis Eugene Summers director, 10 percent owner, officer: President 2410 W. MEMORIAL RD, SUITE C406, OKLAHOMA CITY OK 73134
Douglas Glenn Baker director, officer: CFO, Secretary, Treasurer 2410 W. MEMORIAL RD, SUITE C406, OKLAHOMA CITY OK 73134

Panamera Holdings (Panamera Holdings) Headlines

From GuruFocus